http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0903664-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a5364a0c557fcc87e24261395a3f3f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89ac64d62baaa791ac712c93832985fd |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D411-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D411-04 |
filingDate | 2009-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c03608fead413b61e0e55a4b87c26ca5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f37b8d9799929ca87dc57870acea892 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53f6cd5c77f1b1cce501b188059af3e2 |
publicationDate | 2020-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BR-PI0903664-B1 |
titleOfInvention | method of obtaining a new crystalline form of lamivudine, its hydrochloride salt monohydrate, pharmaceutical formulations and their uses |
abstract | method of obtaining a new crystalline form of lamivudine, its hydrochloride salt monohydrate, pharmaceutical formulations and their uses. the present invention is directed to the method of obtaining a solid crystalline form of lamivudine, form vi, its hydrochloride salt monohydrate and its pharmaceutical formulations. in addition, the present application relates to the use of the crystalline forms of lamivudine monohydrate salt in the preparation of drugs indicated as anti-HIV agent (acquired immunodeficiency syndrome - AIDS). |
priorityDate | 2009-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.